Jelleine-I Membrane Interaction-related Biological Properties and Antimicrobial Activity against MDR, XDR, and

Adrielle Pieve de Castro1, Julio Cesar Moreira Brito2, Wanderson Aparecido Brandão Candido3

  • 1Laboratório de Radioisótopos, Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Campus Pampulha, Belo Horizonte, Minas Gerais 31270-901, Brazil.

ACS Omega
|March 31, 2025
PubMed

Insights

Jelleine-I, an antimicrobial peptide from bee jelly, effectively combats carbapenem-resistant Acinetobacter baumannii. It disrupts bacterial membranes with low toxicity, showing promise as a novel antibacterial agent.

Area of Science:

  • Microbiology
  • Biochemistry
  • Biophysics

Background:

  • Emerging bacterial infections, particularly carbapenem-resistant Acinetobacter baumannii (CRAB), represent a significant global health threat.
  • Antimicrobial peptides (AMPs) are emerging as a promising alternative to conventional antibiotics due to their unique mechanisms of action.
  • Jelleine-I, an AMP derived from bee royal jelly, has shown broad-spectrum antibacterial activity.

Purpose of the Study:

  • To evaluate the efficacy of jelleine-I against clinical isolates of CRAB.
  • To investigate the interaction mechanism of jelleine-I with bacterial membranes.
  • To assess the safety profile of jelleine-I regarding hemolytic activity and cytotoxicity.

Main Methods:

  • Microbiological assays were conducted to determine the minimum inhibitory concentration (MIC) of jelleine-I against CRAB isolates.
  • Biophysical techniques were employed to study the interaction between jelleine-I and biomimetic bacterial membranes.
  • Hemolytic activity assays and cytotoxicity tests on VERO and HaCaT cells were performed.

Main Results:

  • Jelleine-I exhibited significant antibacterial activity against CRAB isolates, with MIC values ranging from 8-16 μM.
  • Biophysical studies indicated that jelleine-I disrupts the organization of phospholipid bilayers, suggesting membrane permeabilization as a key mechanism.
  • Jelleine-I demonstrated negligible hemolytic activity and low toxicity towards mammalian cells.

Conclusions:

  • Jelleine-I is a potent antimicrobial agent effective against multidrug-resistant Acinetobacter baumannii.
  • The primary antimicrobial action of jelleine-I involves the disruption of the bacterial membrane.
  • Jelleine-I represents a promising candidate for the development of novel therapeutics against challenging bacterial infections.

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
804
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
747
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.6K